
Infectious Disease Specialist



No OPD information available
Scabies
Impetigo
Poststreptococcal Glomerulonephritis
Rhabditida Infections
Strongyloidiasis
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Rheumatic Fever
Secernentea Infections
Streptococcal Group A Infection
Chlamydia
Glomerulonephritis
Head Lice
Helminthiasis
Strep Throat
Deborah C. Holt is a female healthcare provider who helps patients with various health issues such as scabies, impetigo, strep throat, and more. She is skilled in treating infections caused by bacteria and parasites like MRSA and head lice. Holt also specializes in conditions like glomerulonephritis and rheumatic fever.
Patients trust Deborah C. Holt because she communicates clearly and listens to their concerns. She explains medical information in a way that is easy to understand, making patients feel comfortable and informed about their health.
To stay updated with the latest medical knowledge, Deborah C. Holt regularly reads research articles and attends conferences. This helps her provide the best possible care for her patients and ensures she is using the most effective treatments available.
Deborah C. Holt works well with her colleagues and other medical professionals. She values teamwork and collaboration, which leads to better outcomes for patients. By sharing knowledge and expertise with others in the medical field, Holt contributes to a supportive and effective healthcare environment.
Holt's dedication to her work has had a positive impact on many patients' lives. Through her expertise and compassionate care, she has helped improve the health and well-being of those she treats. Her commitment to providing quality healthcare services has earned her respect and gratitude from her patients and colleagues.
One of Deborah C. Holt's notable publications is "Correction: Scabies Mite Peritrophins Are Potential Targets of Human Host Innate Immunity," published in PLoS neglected tropical diseases on July 11, 2024. This research highlights her contribution to advancing medical knowledge and improving treatments for infectious diseases.
Deborah C. Holt's commitment to patient care, continuous learning, collaboration with colleagues, and impactful research make her a trusted and respected healthcare provider who positively impacts the lives of those she serves.
Bachelor of Applied Science; Royal Melbourne Institute of Technology; 1992
PhD; University of Sydney; 2000
Graduate Diploma in Information Technology; University of Southern Queensland; 2009
Member of the Australian Society for Parasitology (ASP)
Honorary Senior Research Fellow, Menzies School of Health Research, Darwin, Australia (current; focuses on molecular epidemiology, pathogen genomics, and diagnostics for infectious diseases like scabies and streptococcal infections in tropical/Indigenous communities).
Senior Lecturer in Biomedical Sciences, Charles Darwin University, Darwin, Australia (current; involved in teaching, PhD supervision, and research in bacterial/parasitic pathogens).
Description:Background: Defining the temporal dynamics of invasive Streptococcus pyogenes (group A Streptococcus) and differences between hyperendemic and lower-incidence regions provides crucial insights into pathogen evolution and, in turn, informs preventive measures. We aimed to examine the clinical and temporal lineage dynamics of S pyogenes across different disease settings in Australia to improve understanding of drivers of pathogen diversity. Methods: In this retrospective, multicentre, clinical and genomic epidemiology study, we identified cases of invasive S pyogenes infection from normally sterile sites between Jan 1, 2011, and Feb 28, 2023. Data were collected from five hospital networks across low-incidence regions in temperate southeast Australia and the hyperendemic, tropical, and largely remote Top End of the Northern Territory of Australia. The crude incidence rate ratio (IRR) of bloodstream S pyogenes infection comparing the Top End and southeast Australia and in First Nations people compared with non-First Nations people was estimated by quasi-Poisson regression. We estimated odds ratios (ORs) of intensive care unit (ICU) admission, in-hospital mortality, and 30-day mortality for the Top End versus southeast Australia using logistic regression. Retrieved and successfully sequenced isolates were assigned lineages at whole-genome resolution. Temporal trends in the composition of co-circulating lineages were compared between the two regions. We used an S pyogenes-specific multistrain simulated transmission model to examine the relationship between host population-specific parameters and observed pathogen lineage dynamics. The prevalence of accessory genes (those present in 5-95% of all genomes) was compared across geographies and temporal periods to investigate genomic drivers of diversity. Results: We identified 500 cases of invasive S pyogenes infection in patients in the Top End and 495 cases in patients in southeast Australia. The crude IRR of bloodstream infection for the Top End compared with southeast Australia was 5·97 (95% CI 4·61-7·73) across the entire study period; in the Top End, infection disproportionately affected First Nations people compared with non-First Nations people (5·41, 4·28-6·89). The odds of in-hospital mortality (OR 0·43, 95% CI 0·26-0·70), 30-day mortality (0·38, 0·23-0·63), and ICU admission (0·42, 0·30-0·59) were lower in the Top End than in southeast Australia. Longitudinal lineage analysis of 642 S pyogenes genomes identified waves of replacement with distinct lineages in the Top End, whereas southeast Australia had a small number of dominant lineages that persisted and cycled in frequency. The transmission model qualitatively reproduced a similar pattern of replacement with distinct lineages when using a high transmission rate, small population size, and high levels of human movement-characteristics similar to those of communities in the hyperendemic Top End. Using a lower transmission rate, larger population size, and lower levels of migration similar to those of communities in urbanised southeast Australia, the transmission model qualitatively reproduced a pattern of dominant lineages that cycled in frequency. Despite distinct circulating lineages, the prevalence of accessory genes in the bacterial population was maintained across geographies and temporal periods. Conclusions: In a hyperendemic setting, the replacement of distinct S pyogenes lineages occurred in waves, which could be linked to the disproportionate burden of disease and sparse human population in this setting. The maintenance of bacterial gene frequency could be consistent with multilocus selection. These findings suggest that lineage-specific interventions-such as vaccines under development-should consider disease setting and, without broad cross-protection, might lead to lineage replacement. Background: National Health and Medical Research Council, and Leducq Foundation.
Description:Streptococcus dysgalactiae subspecies equisimilis (SDSE) and Streptococcus pyogenes share skin and throat niches with extensive genomic homology and horizontal gene transfer (HGT) possibly underlying shared disease phenotypes. It is unknown if cross-species transmission interaction occurs. Here, we conduct a genomic analysis of a longitudinal household survey in remote Australian First Nations communities for patterns of cross-species transmission interaction and HGT. Collected from 4547 person-consultations, we analyse 294 SDSE and 315 S. pyogenes genomes. We find SDSE and S. pyogenes transmission intersects extensively among households and show that patterns of co-occurrence and transmission links are consistent with independent transmission without inter-species interference. We identify at least one of three near-identical cross-species mobile genetic elements (MGEs) carrying antimicrobial resistance or streptodornase virulence genes in 55 (19%) SDSE and 23 (7%) S. pyogenes isolates. These findings demonstrate co-circulation of both pathogens and HGT in communities with a high burden of streptococcal disease, supporting a need to integrate SDSE and S. pyogenes surveillance and control efforts.
Description:Deborah Holt, Steven Kho, Christian Doerig, Suji O'connor, Madeleine Ray, Maree Widdicombe, Luke Hall, Angelica Tan, Timothy K Ho, Alessia Hysa, Kaitlin Pekin, Keira Brown
Description:Objective: We describe the public health response to an outbreak of acute rheumatic fever (ARF) in a remote Aboriginal community. Methods: In August 2021, the Northern Territory Rheumatic Heart Disease Control Program identified an outbreak of acute rheumatic fever in a remote Aboriginal community. A public health response was developed using a modified acute poststreptococcal glomerulonephritis protocol and the National Acute Rheumatic Fever Guideline for Public Health Units. Results: 12 cases were diagnosed during the outbreak; six-times the average number of cases in the same period in the five years prior (n=1.8). Half (n=6) of the outbreak cases were classified as recurrent episodes with overdue secondary prophylaxis. Contact tracing and screening of 11 households identified 86 close contacts. Conclusions: This outbreak represented an increase in both first episodes and recurrences of acute rheumatic fever and highlights the critical need for strengthened delivery of acute rheumatic fever secondary prophylaxis, and for improvements to the social determinants of health in the region. Conclusions: Outbreaks of acute rheumatic fever are rare despite continuing high rates of acute rheumatic fever experienced by remote Aboriginal communities. Nevertheless, there can be improvements in the current national public health guidance relating to acute rheumatic fever cluster and outbreak management.
